Clinical Trials
12
Active:7
Completed:3
Trial Phases
3 Phases
Phase 1:10
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (83.3%)Not Applicable
1 (8.3%)Phase 2
1 (8.3%)IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study
Phase 1
Active, not recruiting
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 150
- Registration Number
- NCT05417269
- Locations
- 🇲🇩
Republican Clinical Hospital, ARENSIA Exploratory Medicine, Chisinau, Moldova, Republic of
In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO
Not Applicable
Completed
- Conditions
- Neuromyelitis Optica
- First Posted Date
- 2020-11-16
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 15
- Registration Number
- NCT04629274
- Locations
- 🇫🇷
Hôpital Pierre Wertheimer, Bron, France
🇫🇷Hôpital de Hautepierre, Strasbourg, France
IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)
Phase 2
Terminated
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Drug: IMCY-0098 1350 μgDrug: IMCY-0098 450 μgDrug: Placebo
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 110
- Registration Number
- NCT04524949
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Barbara Davis Center, Aurora, Colorado, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo
Phase 1
Completed
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Drug: IMCY-0098 or placebo
- First Posted Date
- 2019-12-09
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 30
- Registration Number
- NCT04190693
- Locations
- 🇧🇪
Hôpital Erasme, Brussels, Belgium
🇧🇪UZ Brussel, Brussels, Belgium
🇧🇪UZ Gent, Gent, Belgium
Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Imcyse SA
- Target Recruit Count
- 41
- Registration Number
- NCT03272269
- Locations
- 🇧🇪
Hôpital Erasme, Brussels, Belgium
🇧🇪UZ Brussel, Brussels, Belgium
🇧🇪UZ Gent, Gent, Belgium
- Prev
- 1
- 2
- Next
News
No news found